Jay A Grobler

USPTO Granted Patents = 8 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 7(Granted Patents)

Location History:

Gwynedd, PA (US) (2010 - 2020)
North Wales, PA (US) (2018 - 2022)

Company Filing History:

7 out of 2,405

Merck Sharp + Dohme Corp.

Years Active: 2010-2024

Loading Chart...

8 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12171776 - Methods for treatment and prophylaxis of HIV and AIDS (2024-12-24),

2. 11337991 - Methods for the treatment and prophylaxis of HIV and AIDS (2022-05-24),

3. 10624912 - Spirocyclic Pyridotriazine Derivatives useful as HIV integrase inhibitors (2020-04-21),

4. 10548910 - Amido-substituted pyridotriazine derivatives useful as HIV integrase inhibitors (2020-02-04),

5. 10537589 - Methods for the treatment and prophylaxis of HIV and AIDS (2020-01-21),

6. 10081647 - Phosphate substituted quinolizine derivatives useful as HIV integrase inhibitors (2018-09-25),

7. 7807455 - Method to confer cell culture replication activity to different Hepatitis C virus isolates (2010-10-05),

8. 7786287 - Hepatitis C virus assay systems (2010-08-31),

Title: The Innovations of Jay A. Grobler: A Pioneer in HIV Research

Introduction

Jay A. Grobler, an accomplished inventor based in Gwynedd, PA, holds a remarkable portfolio of eight patents. His pioneering work focuses primarily on methods for treating and preventing HIV and AIDS, showcasing his commitment to advancing medical science and improving public health.

Latest Patents

Among his notable contributions, Grobler's latest patents encompass innovative methods for the treatment and prophylaxis of HIV and AIDS. His inventions are directed at inhibiting HIV reverse transcriptase and include protocols for potentially delaying the onset or progression of AIDS or ARC. By administering compounds of specific structural formulas, he has introduced novel approaches that could reshape treatment methodologies for individuals affected by HIV.

Career Highlights

Throughout his career, Grobler has been associated with respected names in the pharmaceutical industry, including Merck Sharp & Dohme Corporation and Merck & Company, Inc. His experience in these organizations has played a critical role in his development as a prominent inventor in the field of antiviral therapies.

Collaborations

Grobler has collaborated with notable colleagues in the field, such as Daria Hazuda and Michael D. Miller. These collaborations have not only contributed to his research but also helped to create a network of innovation focused on combating viral infections.

Conclusion

Jay A. Grobler continues to make significant strides in the field of HIV/AIDS research through his innovative patents and collaborations. His work stands as a testament to the vital role of inventors in addressing some of the most pressing health challenges of our time.

This text is generated by artificial intelligence and may not be accurate.